&SCOPE The NIH Blueprint Neurotherapeutics Network (BPN) has initiated a series of collaborative drug discovery and development projects focused on nervous system disorders. These projects will be developing therapeutic leads through an iterative process of medicinal chemistry optimization and in vitro and in vivo testing. A component of this process will be the conduct of in vivo cardiac safety assessment of compounds. This task will cover 4 canine cardiovascular safety studies ofcompounds generated by the BPN.

Agency
National Institute of Health (NIH)
Type
Research and Development Contracts (N01)
Project #
271201100004I-0-27100003-1
Application #
8561810
Study Section
Project Start
2012-09-13
Project End
2016-09-12
Budget Start
Budget End
Support Year
Fiscal Year
2012
Total Cost
$247,176
Indirect Cost
Name
Sri International
Department
Type
DUNS #
009232752
City
Menlo Park
State
CA
Country
United States
Zip Code
94025